Semiquantitative FP-CIT binding measures
| Binding | DLB (n=27) | AD (n=17) | PD (n=19) | Controls (n=16) |
|---|---|---|---|---|
| Values are means and 95% confidence intervals. | ||||
| FP-CIT, 2β-carbomethoxy-3β-(4-iodophenyl)-N-(3-fluoropropyl)nortropane; DLB, dementia with Lewy bodies; AD, Alzheimer's disease; PD, Parkinson's disease. | ||||
| Ipsilateral caudate | 3.91 | 5.39 | 4.55 | 5.85 |
| 3.52 to 4.30 | 4.90 to 5.87 | 4.28 to 4.82 | 5.30 to 6.40 | |
| Contralateral caudate | 3.97 | 5.65 | 4.57 | 6.02 |
| 3.50 to 4.43 | 5.22 to 6.07 | 4.16 to 4.98 | 5.52 to 6.53 | |
| Ipsilateral anterior putamen | 3.31 | 4.91 | 3.49 | 5.19 |
| 2.90 to 3.73 | 4.47 to 5.35 | 3.05 to 3.93 | 4.72 to 5.67 | |
| Contralateral anterior putamen | 3.44 | 5.10 | 3.27 | 5.14 |
| 3.04 to 3.84 | 4.62 to 5.57 | 2.75 to 3.78 | 4.62 to 5.66 | |
| Ipsilateral posterior putamen | 3.06 | 4.11 | 2.53 | 4.44 |
| 2.63 to 3.50 | 3.72 to 4.49 | 2.31 to 2.76 | 3.99 to 4.87 | |
| Contralateral posterior putamen | 2.95 | 3.96 | 2.14 | 4.43 |
| 2.56 to 3.33 | 3.71 to 4.21 | 1.9 to 2.36 | 4.05 to 4.81 | |